← FDA Drug Approvals (Drugs@FDA)

MYTELASE

NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1956-05-01

Drug application

FDA Application #

NDA010155

Application type

New Drug Application

Brand name

MYTELASE

Generic name

Ambenonium Chloride

Active ingredients

AMBENONIUM CHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

SANOFI AVENTIS US

First approval

1956-05-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown